Stockreport

Soliton Completes Keloid POC Clinical Trial Treatments

Soliton, Inc.  (SOLY) 
PDF HOUSTON, Oct. 1, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform techn [Read more]